Showing results (331-340 of 607) with videos related to
Sort By:
Pageof 61
The Journal of Biological Chemistry|July 18, 2002
Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasisKaren Meir, Daniel Kitsberg, Irit Alkalay, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 16, 2020
Effect of 6-Benzoyl-benzothiazol-2-one scaffold on the pharmacological profile of α-alkoxyphenylpropionic acid derived PPAR agonistsAurélie Hurtevent, Morgan Le Naour, Veronique Leclerc, et al.FEBS Letters|July 19, 2005
Transient impairment of the adaptive response to fasting in FXR-deficient miceBertrand Cariou, Kirsten van Harmelen, Daniel Duran-Sandoval, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2008
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluationCécile Parmenon, Jérôme Guillard, Daniel-Henri Caignard, et al.JHEP Reports : Innovation in Hepatology|January 1, 2025
A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASHJustine Gillard, Martin Roumain, Corinne Picalausa, et al.Molecular and Cellular Biology|March 27, 2013
Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytesSandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, et al.The Journal of Clinical Investigation|April 3, 2002
Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementThierry Claudel, Ekkehard Sturm, Hélène Duez, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 26, 2005
Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalphaAnnelise Genoux, Hélène Dehondt, Audrey Helleboid-Chapman, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 2011
Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophagesGiulia Chinetti-Gbaguidi, Mohamed Amine Bouhlel, Corinne Copin, et al.Atherosclerosis|May 3, 2011
PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASHMorgane Baron, Aurélie S Leroyer, Zouher Majd, et al.Pageof 61